The same pharma companies that profited from the opioid epidemic in the US by hooking patients on their drugs are profiting again as their victims migrate to heroin and participate in needle exchange programs, an attorney told RT. The opioid epidemic is one of the biggest stories of 2017. The number of people dying from big pharma’s prescription narcotics has skyrocketed. But the same pharmaceutical companies that profited from creating the crisis in the first place, and received a slap on the wrist for it, are now profiting from it again, attorney Peter Mougey said in an interview with RT America’s Mike Papantonio. “ The migration from the prescription opioids to heroin is integral to this whole problem. At the end of the day, you are 80 times more likely if you are on heroin to have abused prescription opioids. It’s common sense. No one starts by wrapping a tourniquet around his arm and putting a needle into it, ” he said. “ But something I find even mo